BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24057776)

  • 1. Antidepressant-induced tardive syndrome: a retrospective epidemiological study.
    Lee Y; Lin PY; Chang YY; Chong MY; Cheng AT
    Pharmacopsychiatry; 2013 Nov; 46(7):281-5. PubMed ID: 24057776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotics-induced tardive syndrome: a retrospective epidemiological study.
    Lee MJ; Lin PY; Chang YY; Chong MY; Lee Y
    Clin Neuropharmacol; 2014; 37(4):111-5. PubMed ID: 24992086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN; Matroos GE; Hoek HW; Kahn RS
    Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor and mental side effects of clozapine.
    Gerlach J; Peacock L
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine-related tardive dystonia and tardive dyskinesia: a case report.
    Chen PY; Lin PY; Tien SC; Chang YY; Lee Y
    Gen Hosp Psychiatry; 2010; 32(6):646.e9-646.e11. PubMed ID: 21112461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects.
    Kim JH; Byun HJ
    Clin Neuropharmacol; 2003; 26(6):312-6. PubMed ID: 14646611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
    Chacko RC; Root L; Marmion J; Molinari V; Adams GL
    J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India - a cross-sectional study.
    Desai N; Patel PB; Shah S; Patel TK; Shah SN; Vatsala E
    Int J Psychiatry Clin Pract; 2018 Jun; 22(2):101-108. PubMed ID: 28952832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.
    Revet A; Montastruc F; Roussin A; Raynaud JP; Lapeyre-Mestre M; Nguyen TTH
    BMC Psychiatry; 2020 Jun; 20(1):308. PubMed ID: 32546134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Movement disorders induced by psychiatric drugs that do not block dopamine receptors.
    Friedman JH
    Parkinsonism Relat Disord; 2020 Oct; 79():60-64. PubMed ID: 32871538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders.
    Mentzel TQ; Lieverse R; Bloemen O; Viechtbauer W; van Harten PN;
    J Clin Psychopharmacol; 2017 Apr; 37(2):231-238. PubMed ID: 28141621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive Parkinsonism, orofacial dyskinesia and akathisia following brief exposure to lithium carbonate.
    Muthane UB; Prasad BN; Vasanth A; Satishchandra P
    J Neurol Sci; 2000 May; 176(1):78-9. PubMed ID: 10960299
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-induced movement disorders.
    Jiménez-Jiménez FJ; García-Ruiz PJ; Molina JA
    Drug Saf; 1997 Mar; 16(3):180-204. PubMed ID: 9098656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nosology of tardive syndromes.
    Frei K; Truong DD; Fahn S; Jankovic J; Hauser RA
    J Neurol Sci; 2018 Jun; 389():10-16. PubMed ID: 29433810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.